Trukera Medical

What Trukera Medical does

Trukera Medical was a US-based medical device company founded in 2009 and headquartered in Temecula, California, specializing in corneal health diagnostics. The company's flagship product is the ScoutPro portable tear osmolarity measuring platform — a pen-based handheld device that requires only a 50-nanoliter tear sample, eliminates the need to dock the pen for analysis, and delivers results on-device within seconds with recall capability for up to two prior readings. The system is U.S. CLIA-waived, classifying it as a CLIA Certificate of Waiver test system, and is reimbursable under CPT code 83861, with consumable test cards and control solutions sold separately from the device hardware.

Trukera's commercial focus targets eye care professionals across three segments: cataract and refractive surgeons (primary), optometrists (secondary), and broader eye care facilities and clinics. The device addresses clinically documented pain points, including up to 80% of cataract surgery patients at risk for ocular surface disease, 7x higher dissatisfaction rates in hyperosmolar patients, and a 1-in-6 risk of >1.0 diopter keratometry variation in hyperosmolar cataract patients. The ASCRS preoperative OSD algorithm explicitly recommends pre-operative tear osmolarity testing, which provides a clinical guideline tailwind for adoption. Distribution was historically direct, transitioning to Bausch Surgical's US ophthalmic sales force and Find-a-Rep infrastructure after the acquisition.

In July 2024, Trukera Medical was acquired by Bausch + Lomb Corporation for an undisclosed sum. Following the acquisition, the company ceased operating as an independent entity; ScoutPro is now marketed under the Bausch Surgical brand via bauschsurgical.com and the dedicated GetScoutPro.com portal, with sales leads routed to [email protected] and customer service to [email protected]. Trukera holds US operations only and has no documented subsidiaries, public listing, or disclosed pre-acquisition capital history.

Name

Trukera Medical

Legal name

Trukera Medical

Website

https://trukera.com

Company type

Private

Founded year

2009

Operating status

Acquired

Headcount range

101–250 employees

Short description

Trukera Medical, founded in 2009, developed the ScoutPro portable tear osmolarity system — a CLIA-waived, pen-based diagnostic used by cataract and refractive surgeons, optometrists, and eye care clinics for preoperative ocular surface assessment. The company was acquired by Bausch + Lomb in July 2024.

Ownership category

akta.pro rank

Product category

Ophthalmic Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation) (HLAHAJAF)

Keywords

• Tear osmolarity testing
• Ophthalmic diagnostic devices
• Corneal health diagnostics
• Dry eye diagnostics
• Ocular surface testing

Headquarters

HQ city

Temecula

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. ScoutPro Device and Test Cards: Sale of the ScoutPro portable osmolarity system hardware (pen, charging base) along with consumable osmolarity test cards. The system includes electronic check cards and sold-separately osmolarity control solutions and test cards. CLIA-waived test reimbursable under CPT83861.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Trukera Medical develops and sells the ScoutPro portable tear osmolarity measuring system, a pen-based, handheld diagnostic device that measures tear osmolarity from a 50-nanoliter sample and returns results on the pen within seconds, without docking. The system is sold to eye care professionals (ophthalmologists, optometrists, and surgical facilities) along with consumable osmolarity test cards and control solutions, and the corresponding CLIA-waived test is reimbursable to providers under CPT code 83861.

Product overview

Trukera Medical was a US-based medical diagnostics company specializing in tear osmolarity testing and corneal surface disease diagnostics. The company's primary product was the ScoutPro portable tear osmolarity measuring platform—a pen-based system that provides objective, real-time tear osmolarity measurements for pre-operative planning in cataract and refractive surgery. Trukera Medical was acquired by Bausch + Lomb in July 2024, and the ScoutPro product is now integrated into Bausch + Lomb's US surgical and dry eye disease operations under the Bausch Surgical brand.

Differentiator

Problem solved

Functional benefit

Brands

• ScoutPro: Portable tear osmolarity measuring platform for corneal surface disease diagnostics

Products and services

• ScoutPro Portable Tear Osmolarity Measuring Platform Handheld, pen-based diagnostic system that measures tear osmolarity from a 50-nanoliter sample and returns results on the pen within seconds without docking, with recall of up to 2 prior results. It is a U.S. CLIA-waived test reimbursable under CPT83861, sold to cataract and refractive surgeons, optometrists, and eye care practices for pre-operative ocular surface disease screening and dry eye diagnostics.

Quantifiable outcome

• 7x more patients dissatisfied with cataract surgery outcomes when tear hyperosmolarity is present
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Bausch + Lomb CorporationcoreStrategic or Co-development Partner · 1 July 2024In July 2024, Bausch + Lomb Corporation acquired Trukera Medical, a US-based company specializing in tear osmolarity testing and corneal surface disease diagnostics. Trukera's ScoutPro portable tear osmolarity measuring platform was integrated into Bausch + Lomb's US surgical and dry eye disease operations. This acquisition expanded Bausch + Lomb's diagnostic capabilities in the ophthalmic surgical and dry eye disease market.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• TearLab (now part of Eyecare Leaders): TearLab developed the original TearLab Osmolarity System, the most direct competitor to ScoutPro in clinical tear osmolarity testing for dry eye and ocular surface disease. Both target the same ophthalmology/optometry clinical workflow with a point-of-care osmolarity assay.
• I-MED Pharma: I-MED Pharma markets the I-PEN Osmolarity System, a handheld tear osmolarity device competing directly with ScoutPro in dry eye diagnosis. Targets the same eye-care professionals with a portable point-of-care osmolarity test.

Broad incumbents

• Bausch + Lomb Corporation: Parent company of Trukera and a global ophthalmic incumbent with broad franchises in cataract surgical equipment, pharmaceuticals, and consumer vision care. Comparable as the broader incumbent in whose portfolio ScoutPro now competes for attention alongside IOLs, viscoelastics, and refractive equipment.
• Alcon: Global ophthalmic leader in surgical (cataract IOLs, vitreoretinal) and vision care. Comparable as a broad incumbent selling cataract surgical equipment and dry eye products into the same ophthalmic surgical and optometric channels targeted by ScoutPro.
• Johnson & Johnson Vision: Major ophthalmic incumbent with cataract IOLs, refractive surgery (LASIK), and ocular surface therapeutics. Comparable for its overlapping reach into the cataract/refractive surgical and dry eye markets where ScoutPro is positioned.
• Carl Zeiss Meditec: Ophthalmic diagnostic and surgical equipment incumbent with cataract surgical microscopes, OCT, and ocular surface imaging tools. Comparable as a multi-modality diagnostics and surgical vendor selling into the same ophthalmic surgical practices.
• Topcon Healthcare: Broad ophthalmic equipment and digital health vendor with diagnostic imaging, refraction, and ocular surface instruments. Comparable for selling multimodal diagnostic devices into the same optometry and ophthalmology practices targeted by ScoutPro.

Emerging players

• Heidelberg Engineering: Specialized ophthalmic imaging company with confocal microscopy (HRT) and OCT platforms used in ocular surface and anterior segment diagnostics. Comparable as an emerging diagnostics player offering complementary ocular surface disease assessment tools.
• Lacrivera: Emerging ocular surface and dry eye diagnostics company developing point-of-care tools for tear film assessment. Comparable as a smaller diagnostics player addressing overlapping clinical use cases in dry eye and ocular surface disease management.

Others

• Reichert Technologies (Ametek): Long-established ophthalmic instrument maker (tonometry, refraction, corneal measurement). Comparable as an adjacent ophthalmic instrumentation supplier whose devices are commonly co-located with osmolarity testing in clinical workflows.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/TrukeraMedical
• Facebookfacebook.com/TrukeraMedical
• LinkedInlinkedin.com/company/trukera-medical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trukera Medical